≥99% HPLCIntranasal spray

NAD⁺ / NAD (Intranasal Spray)

Name: NAD⁺ / NAD (Intranasal Spray)
Brand: Dripfy
Availability: InStock

What it is?

Nicotinamide Adenine Dinucleotide (NAD⁺) is a central metabolic coenzyme involved in cellular energy production and DNA repair biology. Presented here as a spray format, it is positioned for longevity protocols where mitochondrial function, cognitive performance, and cellular resilience are monitored as key endpoints.

Dripfy Advantage

Mitochondrial energy cofactor: Functions as a core coenzyme in mitochondrial energy production pathways, supporting cellular ATP-generation dynamics.
DNA repair support: Associated with DNA repair pathway activity and cellular resilience markers under stress and ageing conditions.
Sirtuin pathway activation: Supports signalling linked to sirtuin activity, frequently referenced in longevity and metabolic regulation frameworks.
Cellular communication integrity: Positioned to support signalling networks that maintain cellular coordination and repair capacity over time.
Convenient delivery format: Spray administration supports protocol accessibility and consistent use where non-injectable delivery is preferred.

Clinical Applications & Therapeutic Potential

Cellular energy endpoints: Potential support for improved energy-related biomarkers and mitochondrial function indices.
Neurocognitive markers: Potential improvements in cognitive performance endpoints and neuroprotection-associated markers (context-dependent).
Healthy ageing frameworks: Positioned for broader longevity protocols targeting functional preservation and resilience.
Daily protocol compliance: Spray format supports adherence in structured longevity routines, enabling consistent exposure in long-term designs.

Composition & Formulation

Molecule: Nicotinamide adenine dinucleotide (NAD⁺ / NAD redox couple)
Format: Intranasal spray version (NAD) used in certain research/consumer contexts; NAD⁺ is widely studied as a central redox cofactor

€496

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Intranasal spray
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

NAD⁺ / NAD (Intranasal Spray)

Investigational NAD+ coenzyme, intranasal spray format · Intranasal spray

D· Preliminary evidence

NAD+ (nicotinamide adenine dinucleotide) is a central coenzyme in mitochondrial energy production, DNA-repair enzyme activity and sirtuin signalling, all of which decline with age. This product presents NAD in an intranasal spray, on the premise of supporting cellular energy and resilience. While NAD+ biology and its precursors are widely studied, controlled human evidence for an intranasal NAD spray specifically is lacking.

Studied use areas

Mitochondrial energy-metabolism support (research interest)
DNA-repair and cellular-resilience pathways
Sirtuin-linked longevity signalling (investigational)
Cognitive-performance and general vitality frameworks (exploratory)

Safety & status

Intranasal-spray delivery of NAD is unproven; efficacy and safety are not established in controlled trials
Use only under physician supervision; not a licensed medicine via EMA or MHRA
Nasal-route products may cause local irritation and are not appropriate for everyone

⚕ Clinical note: This is educational information only and not medical advice. This NAD intranasal spray is investigational; any use should be individualised and determined by a treating physician under appropriate supervision.

Evidence: Grade D — investigational; NAD+ biology is well established, but the intranasal-spray route has essentially no controlled human efficacy data. · References: Peer-reviewed NAD+ and sirtuin metabolism literature; Clinical studies of NAD+ precursors (e.g. NR/NMN); EMA/MHRA guidance on food-supplement versus medicinal claims